TrianglePUBLICATIONS · 22430271
Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- J Clin Oncol
- Publication date
- 2012 May 1
- First author
- Uldrick TS
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Uldrick TS
- type
- Author
- name
- Wyvill KM
- type
- Author
- name
- Kumar P
- type
- Author
- name
- O'Mahony D
- type
- Author
- name
- Bernstein W
- type
- Author
- name
- Aleman K
- type
- Author
- name
- Polizzotto MN
- type
- Author
- name
- Steinberg SM
- type
- Author
- name
- Pittaluga S
- type
- Author
- name
- Marshall V
- type
- Author
- name
- Whitby D
- type
- Author
- name
- Little RF
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Uldrick TS
- type
- Author
- name
- Wyvill KM
- type
- Author
- name
- Kumar P
- type
- Author
- name
- O'Mahony D
- type
- Author
- name
- Bernstein W
- type
- Author
- name
- Aleman K
- type
- Author
- name
- Polizzotto MN
- type
- Author
- name
- Steinberg SM
- type
- Author
- name
- Pittaluga S
- type
- Author
- name
- Marshall V
- type
- Author
- name
- Whitby D
- type
- Author
- name
- Little RF
- type
- Author
- bibliography ids
- nci-bib-32f23d4ffd9cb861149525b1
- book metadata
- content sha256
- 8bb506c0555fce3113c8aeb6b4824b7b2c752d7ac5c702ffa3844fd0da39f00f
- document type
- citation
- dois
- 10.1200/JCO.2011.39.6853
- electronic publication date
- display
- 2012 Mar 19
- precision
- day
- year
- 2012
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22430271
- immutable id
- pubmed:22430271@8bb506c0555fce3113c8aeb6b4824b7b2c752d7ac5c702ffa3844fd0da39f00f
- journal
- abbreviation
- J Clin Oncol
- issn electronic
- 1527-7755
- issn print
- 0732-183X
- issue
- 13
- name
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology
- nlm unique id
- 8309333
- pages
- 1476-83
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22430271
- provenance
- batch id
- c95be1d0b8cf19942816
- provider
- NCBI PubMed ESummary
- record sha256
- 2638858268912bd53147f546b728c2c5361807ee180d460b48667ee82d61b8a6
- response sha256
- a96bb680a8f3690267e009557d1b07aab71455ba44aeba18695d98a3eeb5fcf2
- retrieved at
- 2026-09-09T23:46:47.691937+00:00
- publication date
- display
- 2012 May 1
- precision
- day
- year
- 2012
- publication types
- Clinical Trial, Phase II
- Journal Article
- Research Support, N.I.H., Extramural
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Phase II study of bevacizumab in patients with HIV-associated Kaposi's sarcoma receiving antiretroviral therapy.
Preserved source evidence · Not medical advice